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ABSTRACT
The processes that govern fracture repair rely on many mechanisms that recapitulate embryonic skeletal development. Hox genes
are transcription factors that perform critical patterning functions in regional domains along the axial and limb skeleton during
development. Much less is known about roles for these genes in the adult skeleton. We recently reported that Hox11 genes, which
function in zeugopod development (radius/ulna and tibia/fibula), are also expressed in the adult zeugopod skeleton exclusively in
PDGFRaþ/CD51þ/LepRþ mesenchymal stem/stromal cells (MSCs). In this study, we use a Hoxa11eGFP reporter allele and loss-of-
function Hox11 alleles, and we show that Hox11 expression expands after zeugopod fracture injury, and that loss of Hox11 function
results in defects in endochondral ossification and in the bone remodeling phase of repair. In Hox11 compound mutant fractures,
early chondrocytes are specified but show defects in differentiation, leading to an overall deficit in the cartilage production. In the
later stages of the repair process, the hard callus remains incompletely remodeled in mutants due, at least in part, to abnormal bone
matrix organization. Overall, our data supports multiple roles for Hox11 genes following fracture injury in the adult skeleton. © 2017
American Society for Bone and Mineral Research.
KEY WORDS: SKELETAL INJURY/FRACTURE HEALING; MESENCHYMAL STROMAL/STEM CELLS; MOLECULAR PATHWAYS–DEVELOPMENT; HOX
GENES; ENDOCHONDRAL OSSIFICATION–CARTILAGE
Introduction
The mammalian skeleton boasts a remarkable capacity forregeneration following injury. It is one of only a few
postnatal processes that are truly regenerative, reestablishing
original structure and function without scar formation. Interest-
ingly, many of the mechanisms that govern fracture callus
formation and remodeling include those that are also required
during embryonic skeletal development.(1–5) The expression of
several genes required for long-bone formation in the embryo
(endochondral ossification) are also expressed in the fracture
callus, and the patterns of expression and overall histology show
similarities to those observed in the growth plate.(3–5) A group of
transcription factors that have received little attention in this
process are the Hox genes.
Hox genes are homeodomain-containing transcription factors
that are required for region-specific patterning of the skeleton
during development. They are expressed and function in
spatially distinct domains along the anterior-posterior (AP)
body axis and proximal-distal limb axis.(6–8) The 39 mammalian
Hox genes are subdivided into 13 paralogous groups (Hox1 to
Hox13) based on sequence similarity and position within theHox
cluster. Genetic studies show that members of each paralogous
group display a remarkable degree of functional redundancy
with one another; loss of function of entire paralogous groups
results in severe, region-specific skeletal defects along the AP
axis.(8–15) The posterior Hox genes (Hox9 to Hox13) were also
co-opted in limbed vertebrates to function in proximal to distal
patterning of the limbs.(10,15–20) The Hox11 paralogs instruct
proper development of the zeugopod elements of the limb
skeleton (radius/ulna and tibia/fibula).(15–17) Loss of Hox11
function results in severe patterning defects of the zeugopod
while the remainder of the limb develops normally. Previous
studies have reported Hox expression during fracture heal-
ing(21–23); however, Hox gene function in this process has not
been directly tested.
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The maintenance of Hox11 expression in the perichondrium/
periosteum surrounding the developing skeletal elements of the
limbs into late stages of embryonic development(24) led us to
question whether Hox genes continue to be expressed and
function beyond early patterning events in the embryo. Recently,
we reported that Hox11 genes are expressed exclusively in
mesenchymal stem/stromal cells (MSCs) in the bonemarrow and
periosteum at adult stages.(25) Using a Hoxa11eGFP insertion
allele, we demonstrated that Hoxa11eGFPþ cells are exclusively
expressed in PDGFRaþ, CD51þ, and Leptin Receptorþ (LepRþ)
cells, markers that have been previously characterized to enrich
for mesenchymal progenitor activity in bone marrow non-
endothelial stroma and to contribute to fracture healing.(26–28)
Importantly, we reported that the adult expression and function
of Hox11 genes is spatially restricted to same region in which
these genes are expressed and function in the embryo (the
zeugopod for Hox11 in the limb skeleton), and that other adult
Hox gene expression profiles also follow this pattern in other
regions of the skeleton.(25,29) Together, this work suggests that
Hox genes are expressed and function with regional specificity in
adult skeletal MSCs.
In this study, we explore the defects associatedwith the loss of
Hox11 function in fracture repair using loss-of-function mouse
models. At early stages of repair, we find that Hox11 function is
required for chondrocyte differentiation during fracture healing.
In addition, we report evidence for bone modeling defects in
Hox11 mutants; these mutant fractures display defects in the
remodeling phase of repair are unable to remodel to regain
normal morphology. Our work is the first to demonstrate adult
function(s) for Hox11 genes in skeletal repair and regeneration
following fracture injury.
Materials and Methods
Mice
All mice were maintained in a C57BL/6 background. Male and
female mice either double-heterozygous or single-heterozygous
for the Hoxa11 and Hoxd11 null alleles were mated to generate
compound mutant animals.(16) All animals in the study were
maintained on a C57/Bl6 background and group-housed in
standard condition, unless separation was required due to
fighting. Animals heterozygous for the Hoxa11eGFP allele were
generated by traditional breeding strategies as described.(30) To
assess spatial variation in bone fracture repair based on local Hox
expression levels, three distinct fracture-healing models were
employed: ulnar, tibial, and femoral. All animals were anesthe-
tized with isoflurane during each procedure and provided
buprenorphine preoperatively and postoperatively. Carprofen
was also given during the recovery period. Postoperative
radiographs were taken immediately following fracture (Faxitron
X-Ray; Faxitron, Tucson, AZ, USA) to ensure proper fracture
location. All animals were fully weight bearing within 1 hour
following surgery. Full fracture methods are described in detail in
the Supporting Information. All animal experiments described in
this article were reviewed and approved by the University of
Michigan’s Committee on Use and Care of Animals, Protocol
#PRO00006651 (Wellik) and Protocol #PRO00006763 (Goldstein).
Additional materials and methods may be found in the
Supporting Information and include the following: fracture
methods; X-ray and micro–computed tomography (mCT);
histology; immunohistochemistry; and histomorphometric
measurements and Raman spectroscopy.
Results
Hox11 is expressed throughout fracture repair
Fracture healing can be loosely defined by distinct phases of
anabolic (callus expansion) and catabolic (callus remodeling)
responses to the injury.(31,32) Resident MSCs in the skeleton (from
the periosteum and bone marrow) provide the major source of
progenitors for the repair process.(28,33–37) Hoxa11eGFP, at adult
stages, is visualized in both theperiosteum and bonemarrow as a
progenitor-enriched, non-endothelial, MSC population.(25) To
explore a possible role for Hox11 genes in the repair process, the
expression of Hoxa11eGFP was examined following fracture
injury of both the ulna or the tibia (forelimb or hindlimb
zeugopod) using an anti-GFP antibody developed with alkaline
phosphatase. Sectionsweredevelopedwithout primary antibody
to confirm that staining is specific (Supporting Fig. 1D). During
hematoma formation (0.5 weeks postfracture [WPF]),
Hoxa11eGFPþ cells begin to expand from the periosteum
(Fig. 1A, Supporting Fig. 1A). During the soft (cartilage) callus
(1.5 WPF) and hard (bony) callus (3 WPF) stages, significant
expansion of Hoxa11eGFPþ cells throughout the callus is
observed. Hoxa11eGFPþ cells are present at the center of the
soft callus, in the medullary space at the site of injury, and in the
expanded periosteal stromal layer that surrounds the newly
formed fracture callus (Fig. 1B; Supporting Fig. 1B). At hard callus
stages, Hoxa11eGFPþ cells are observed lining the woven bone
surfaces (Fig. 1C). Hox11 continues to be expressed well into
remodeling stages as evidenced by extensive Hoxa11eGFP
expression at 6 WPF (Supporting Fig. 1C). Importantly, our
previous work shows that Hox11-expressing cells do not overlap
with any markers of differentiated cells throughout the fracture
healingprocess (includingosteoblasts, osteoclasts,macrophages,
endothelial cells, neurons, and chondrocytes), andflowcytometry
demonstrates a cell-surface marker profile that is consistent with
expression of Hoxa11eGFP exclusively in MSCs.(25)
Hox11 loss-of-function mice display defects during
fracture healing
To assess a role for Hox11 genes in the response to fracture
injury, an ulnar fracture model was employed in Hox11
compound mutants (referred to as Hox11 mutant) in which
three Hox11 alleles are mutated. Retention of one wild-type
allele is sufficient to prevent the developmental skeletal defects
observed in four-allele mutant animals.(17,24) X-rays and mCT
scans performed at several time points following fracture injury
(in accordance with accepted protocols(38)) reveal abnormal
fracture healing in Hox11mutants. During the early response to
injury, 1.5WPF, there are no apparent differences in ossification
between mutants and controls (Fig. 2A). However, by mid-stage
healing (3WPF) Hox11 mutant animals demonstrate a delay in
fracture gap union (Fig. 2B).
During remodeling stages of healing (>6WPF), two pheno-
types are observed in Hox11 mutant animals. First, a significant
number of animals exhibit non-union fractures (Fig. 2F). Second,
mutant animals that display fracture union demonstrate a
dramatic delay in remodeling. Histological analyses reveal a
significant amount of woven bone remaining in the bone
marrow space at 6 and at 12WPF compared to wild-type control
fracture injuries that have remodeled this space by these time
points (Fig. 2C, D). Notably, this incomplete remodeling remains
at 21WPF (Fig. 2E). mCT analyses support these observations.
Although the callus volume of control fractures declines with
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time after injury, indicative of remodeling, the callus volume in
Hox11 mutant fracture injuries remains elevated (Fig. 2G).
Loss of Hox11 function reduces chondrocyte
differentiation in the early callus
Processes required for early callus formation were evaluated in
order to understand the cellular mechanism for delayed callus
bridging in Hox11mutant fracture injuries. New bone formation
in the callus is accomplished by intramembranous and
endochondral ossification, distinct processes that act simulta-
neously following fracture to promote repair at the site of
injury.(1,31) Vascularization is critical for this process, and
ischemic injuries result in non-union fractures that require
medical intervention.(39,40)
In both control andmutant fracture injuries, newbone forms at
the outer callus, along the periosteal surface, characteristic of
intramembranous ossification (Fig. 3A, B). In both groups, these
regions exhibit high levels of Osterix expression (a marker of
osteoblasts) and are highly vascularized (platelet endothelial cell
adhesionmolecule [PECAM]) (Fig. 3B). No defects are observed in
the overall vascularization of Hox11 mutant calluses (Fig. 3C, D).
To evaluate endochondral ossification, histomorphometry
measurements were performed on SafraninO/Fast Green-
stained sections of early calluses. At three time points
postfracture (1.5WPF, 3WPF, and 6WPF), the proportion of
the callus comprised of mesenchyme, cartilage, or woven bone
was measured (Fig. 4A, B). Results reveal a decrease in woven
bone and an increase in mesenchyme at the earliest stages of
Hox11mutant callus formation compared to controls (Fig. 4A, B);
a result consistent with delayed union observed by X-ray and
mCT analyses (Fig. 2). Notably, a significant reduction in cartilage
formation (Safranin O) is observed in Hox11 mutant fractures at
all stages examined (Fig. 4A, B).
Fig. 1. Hox11 is expressed throughout fracture injury in the limb zeugopod. Limb schematic depicts Hoxa11eGFP regional expression (green) and the
fracture callus in the zeugopod region (tibia). Hox11 expression is shown using a GFP primary antibody and developing with alkaline phosphatase.
(A) Hox11 is expressed at low levels in the hematoma. (B) Hox11 expression expands at 1.5WPF including the intramedullary space () and in the
expanded periosteum surround the callus (arrows). (C) Hox11 is expressed near woven bone surfaces in the hard callus at 3 WPF. WPF¼weeks
postfracture, cb¼ cortical bone, m¼marrow/intramedullary space, wb¼woven bone, red dashed line¼ fracture line.
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To further understand the cartilage defect, immunohis-
tochemistrywas performed for specificmarkers of chondrogenic
differentiation. Sox9 and Sox5, the earliest transcription factors
expressed during chondrocyte differentiation, are expressed
broadly in both control and Hox11 mutant fracture calluses
(Fig. 4Ci, Supporting Fig. 2A). However, mature cartilage
markers, Collagen2a1 (resting, proliferating, and prehypertro-
phic chondrocytes) and Collagen10a1 (hypertrophic
Fig. 2. Loss of Hox11 function results in defects following fracture injury. (A–D) X-rays (top panels) and cross-sectional views of mCT (lower panels) in
control and in Hox11 mutant animals. (A) At 1.5 WPF, X-ray and mCT images are comparable between groups. (B) At 3 WPF, controls are bridged and
mutants are not. (C, D) At 6 WPF and 12WPF, most mutants are now bridged, but exhibit delayed remodeling compared to controls. (E) Cross-sectional
views of mCT at 21WPF persistent and incomplete bone remodeling in mutant animals. (F) 100% of control animals demonstrate union fractures
compared to 71%ofHox11mutant animals. Statistical analysis carried out by two-tailed Fisher’s exact test and by two-tailed chi-square test; p< 0.05. (G)
mCT analysis shows statistically significant maintenance of callus volume at late stages in mutants. Statistical analysis carried out by Student’s t test;
p< 0.05. WPF¼weeks postfracture.
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chondrocytes), are clearly reduced in mutants (Fig. 4Cii–iii). The
ossification of cartilage as visualized by Von Kossa staining is
abundant in control calluses and this is also significantly reduced
in the Hox11 mutant callus (Fig. 4D). Areas of mesenchyme can
also be visualized at the center of Hox11mutant calluses by this
method (Fig. 4D). Combined with the callus histomorphometry
(increased mesenchyme and decreased Safranin O), these data
indicate a defect in chondrocyte differentiation that limits
endochondral ossification.
Bone modeling is disrupted to due loss of Hox11
function
By late stages of repair, the majority of Hox11 mutant animals
demonstrate successful fracture union (Fig. 2F). However,
during the remodeling phases of repair, mutant animals
display a notable impairment as late as 21 WPF with all mutant
animals retaining significant woven bone throughout the
central callus region, unlike control animals that have largely
re-established prefracture morphology by 12WPF (Fig. 2E, G).
To explore a possible cause for this phenotype, osteoclasts
were examined. Quantification of tartrate resistant acid
phosphatase (TRAP) reveals that osteoclasts are present at a
similar density in control and mutant fracture injuries (Fig. 5A,
B). Cathepsin K, an enzyme that functions in bone-resorbing
osteoclasts,(41) is similarly expressed in both groups (Fig. 5C).
However, close examination reveals many osteoclasts in Hox11
mutant fracture injuries are enlarged and detached from the
bone surface, which may contribute to incomplete remodeling
of Hox11 mutant fracture injuries (Fig. 5D). Maintained osteoid
at the bone surface can explain such an observation; however,
Von Kossa and basic fuchsin staining does not reveal
differences in osteoid deposition between controls and
mutants (Supporting Fig. 3).
Fig. 3. Intramembranous ossification and vascularization are unchanged in Hox11 mutant fractures. (A) mCT analysis of outer regions of callus show
comparable bone formation in regions of intramembranous ossification. Yellow line shows approximate region of cross-sectional images. (B) Osterix and
PECAM-stained sections show bone formation and vascularization in regions of intramembranous ossification. (C, D) PECAM-staining in controls and
Hox11 mutants shows comparable vascularization in the early callus (1.5 WPF). cb¼ cortical bone.
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Fig. 4. Chondroctye differentiation and endochondral ossification is disrupted in the Hox11mutant callus. (A, B) Histomorphometric quantifications of
themesenchymal, woven bone and cartilage areas from Safranin O/Fast Green-stained sections at 1.5, 3, and 6WPF. Cartilagewas designated by Safranin
O. Woven bone and mesenchyme were designated visually; the latter refers to non-woven bone, non-safranin O-positive area. Abundant cartilage
formation is visualized in center regions of control calluses; mesenchyme is maintained in similar regions of mutant calluses. Statistical analysis carried
out by Student’s t test; p< 0.05. (C) Sox9, Collagen2a1 and Collagen 10a1-stained sections at 1.5WPF show chondrocyte differentiation in control and
mutant calluses. (D) Von Kossa–stained sections show unbridged callus at 3 WPF in mutant fractures and undifferentiated mesenchyme at the center of
the callus. wb¼woven bone; WPF¼weeks postfracture.
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Fig. 5. Osteoclasts are present, express markers of resorption in the Hox11 mutant callus. (A) TRAP-stained callus sections from control and Hox11
mutant animals at 3 and 6 WPF show TRAPþ osteoclasts in calluses. (B) Histomorphometric quantification of osteoclasts per bone surface (%) and
number of osteoclasts per 1mm of bone surface is comparable in controls and mutants. (C) Cathepsin K-stained callus sections from control and mutant
animals show positive staining in controls and mutants. Safranin O/Fast Green staining on the same sections shows the overlap of CathepsinK with
woven bone areas. (D) Images of large, detached osteoclasts in the Hox11mutant callus (blue arrows) compared to control osteoclasts that are flat and
attached to the bone surface (black arrows). WPF¼weeks postfracture, wb¼woven bone.
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Previous work demonstrates that Hox11 genes are not
expressed in hematopoietic cells at any stage of development
or repair(24,25); therefore, the defects associated with reduced
osteoclast attachment are presumably non-cell autonomous,
but may be caused by alterations in bony matrix. By mCT,
measurements of bone and mineral density (BV/TV, BMD, BMC,
and tissue mineral density [TMD]) are unchanged between
controls and Hox11 mutants at all time points examined
(Table 1), and is consistent with a recent study of compound
mutants through postnatal stages of development.(42) Raman
spectroscopy was used to provide a more powerful analysis of
possible bone matrix abnormalities in Hox11 mutant animals.
This unique andmore sensitive tool is capable of assessing bone
quality parameters by measuring relative changes in mineral-to-
matrix ratios, mineral crystallinity, and collagen crosslink ratios,
providing information on tissue-level material properties.(43) For
this study, the technique was employed on woven bone in the
fracture callus, and on cortical bone outside the callus in the
fractured limb and on the contralateral limb. Analyses of these
fractures show no statistically significant changes in mineral
crystallinity, and are consistent with mCT results (Fig. 6A,
Table 1).(42) However, mineral-to-matrix ratios in the cortical
bone of Hox11 mutants are significantly increased compared to
controls (Fig. 6B). Together, these data are consistent with the
absence of changes in mineralization, but abnormalities in the
proper organization of bone matrix.
Specific matrix bands related to the collagen crosslinks ratio
could not be analyzed by Raman spectroscopy in this study due
to polymer interference of the poly(methyl methacrylate)
(PMMA)-embedded specimens (data not shown). To further
evaluate defects in matrix organization, Picrosirius Red staining
combined with polarized light microscopy was performed.(44)
Using this technique, an organized or directional matrix appears
linear (green) under polarized light, whereas disorganized or
multidirectional matrix (red/orange) yields a basket-weave
appearance. New woven bone generated in the fracture callus
is highly disorganized in both control andHox11mutant calluses
as is expected for this rapid bone deposition (Fig. 6C). However,
Hox11mutant animals also display significant disorganization in
their cortical bonematrix (Fig. 6D, Supporting Fig. 4). In controls,
Sclerostin staining osteocytes are regularly spaced and well
organized in the bone matrix (Fig. 6E). In Hox11 mutants,
however, osteocytes embedded in cortical bone exhibit
irregular spacing and areas of aggregation within the bone
matrix (Fig. 6E).
Discussion
Our understanding of Hox transcription factors in the skeleton is
largely limited to embryonic development; however, recent
studies have shown that Hox genes are re-expressed during
repair, consistent with possible functions during fracture
repair.(21–23,45) Transcriptome analyses have shown broad
increases in the expression of various Hox genes throughout
fracture repair of the femur.(21,22) Additionally, differential
expression (and function) of Hox genes has been suggested
as a cause for scar formation in a transplant study where
periosteal progenitor cells from different anatomical locations
were swapped in fracture injuries.(23) When Hoxþ cells were
transplanted into a mandibular injury (a site normally negative
for Hox-expressing cells), chondrocytes formed and differenti-
ated to cartilage at this injury site. This is a skeletal region that
would have normally healed by intramembranous ossification.
This supports a possible function for Hox genes in adult skeletal
Table 1. mCT Parameters Measured During Fracture Injury Repair
Unfractured 1.5 weeks postfracture 3 weeks postfracture
Measured
parameter
Control
(n¼ 6)
Hox11 mutant
(n¼ 8)
Control
(n¼ 5)
Hox11 mutant
(n¼ 8)
Control
(n¼ 5)
Hox11 mutant
(n¼ 6)
Callus volume
(mm3)
0.45 (0.03) 0.52 (0.04) 1.81 (0.45) 2.75 (0.72) 1.74 (0.22) 1.59 (0.50)
Bone volume (mm3) 0.32 (0.01) 0.35 (0.03) 0.52 (0.13) 0.78 (0.22) 0.57 (0.08) 0.57 (0.21)
BV/TV (%) .71 (0.02) 0.67 (0.02) .32 (0.18) 0.28 (0.03) 0.33 (0.05) 0.35 (0.05)
BMD (mg/cm3) 839.6 (40.7) 740.2 (61.8) 486.0 (173.2) 424.1 (101.1) 511.3 (30.4) 480.2 (77.5)
BMC (mg) .36 (0.01) 0.39 (0.05) 0.82 (0.15) 1.07 (0.31) 0.89 (0.08) 0.78 (0.32)
TMD (mg/cm3) 977.0 (32.0) 905.6 (85.4) 935.3 (101.8) 860.7 (101.4) 838.0 (31.3) 792.5 (74.3)
6 weeks postfracture 12 weeks postfracture 21 weeks postfracture
Measured
parameter
Control
(n¼ 5)
Hox11 mutant
(n¼ 6)
Control
(n¼ 5)
Hox11 mutant
(n¼ 4)
Control
(ND)
Hox11 mutant
(n¼ 5)
Callus volume
(mm3)
1.45 (0.25) 1.61 (0.62) 0.99 (0.12) 1.52 (0.27) ND 1.49 (0.16)
Bone volume (mm3) 0.79 (0.13) 0.81 (0.28) 0.63 (0.10) 0.93 (0.04) ND 0.86 (0.06)
BV/TV (%) 0.55 (0.07) 0.51 (0.05) 0.64 (0.04) 0.63 (0.09) ND 0.58 (0.04)
BMD (mg/cm3) 664.3 (83.7) 606.4 (60.2) 796.2 (49.3) 817.7 (104.3) ND 751.2 (24.3)
BMC (mg) 0.96 (0.17) 0.97 (0.34) 0.79 (0.13) 1.22 (0.07) ND 1.09 (0.12)
TMD (mg/cm3) 896.8 (48.6) 866.9 (37.1) 1036.2 (26.4) 1054.0 (72.6) ND 983.3 (57.1)
Statistical analyses were carried out by Student’s t test; p< 0.05. Parameters measured include callus volume, total bone volume, BV/TV, BMD, BMC,
and TMD.BV/TV¼bone volume fraction; BMD¼bone mineral density; BMC¼bone mineral content; TMD¼ tissue mineral density; ND¼no data
collected.
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regeneration, but genetic loss-of-function analyses at endoge-
nous sites of potential Hox activity have been lacking.
We report clear, regional expansion of Hox11-expressing cells
in response to fracture injury of the zeugopod, the region of the
skeleton that expresses Hox11 genes during development.
Complete loss of Hox11 paralogous group function results in
severe malformations during embryonic development and
neonatal lethality that preclude adult studies. Using a sensitized
background of compound Hox11 loss-of-function animals, we
show that loss of Hox11 function results in defects in
endochondral ossification during early callus formation and in
impairment of the bone remodeling phase of repair.
We provide evidence that Hox11 genes function in cartilage
differentiation following fracture injury. The differentiation of
Hox-expressing MSCs to chondrocytes during soft callus
formation is disrupted. Mesenchyme is abundant in the Hox11
mutant callus, and Sox9 and Sox5 (expressed in mesenchymal
progenitors) are expressed broadly; however, downstream
differentiationmarkers Collagen2a1, Collagen10a1, and Safranin
O are markedly reduced. These combined data support that loss
of Hox11 function results in the failure of mesenchyme to
differentiate to mature chondrocytes. Notably, these results are
consistent with defects reported during embryonic limb
formation with loss of Hox11 function and with our more recent
Fig. 6. Bone matrix organization is disrupted due to the loss of Hox11 function. (A, B) Raman spectroscopy of woven bone callus and cortical bone
outside the callus from controls andHox11mutants at 3WPF. Parametersmeasured includemineral crystalinity (A) andmineral tomatrix [ProþHyp] ratio
(B). Fx¼ fractured limb, Contra¼ contralateral limb. (C, D) Picrosirius red-stained sections with brightfield (top panels) or polarized light microscopy
(bottom panels) for woven bone in fracture callus (C) and cortical bone out the callus (D). Arrows point to disorganized matrix in mutants. (E) Sclerostin-
stained cortical bone shows disorganized osteocytes in Hox11 mutants. WPF¼weeks postfracture.
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work that demonstrates loss of chondrogenic differentiation in
vitro from MSCs that carry these same mutations.(25,46) The
decrease, but not complete absence, of cartilage in this fracture
model is likely the result of incomplete loss of Hox11 gene
function (one wild-type remains in Hox11 compound mutants).
We also show that loss of Hox11 leads to defects during the
remodeling phase after fracture injury. Osteoclasts are present,
butmany are detached from the bonymatrix. Our observation of
detached osteoclasts could be a result of changes in bonematrix
disorganization in Hox11 compound mutant animals, but this
will require further study.
The restriction of paralogous group expression and function
in skeletal patterning at specific anatomical locations during
embryonic development is a key feature of Hox genes. The work
described here supports a continued function for Hox genes in
the vertebrate skeleton during adult fracture repair. Our
previous worked showed that Hox11 expression remains
regionally restricted throughout postnatal growth, is main-
tained in the adult skeleton and expands in fracture injuries only
in the zeugopod. Regional expression in the adult animalmirrors
the pattern of expression and function during embryonic
skeletal development. Importantly, we also reported that femur
(stylopod) fracture injuries performed on Hox11 loss-of-function
animals display no defects in the repair process.(25) We would
predict that different Hox paralogs perform similar activities at
different anatomical locations. For example, Hox10 paralogous
group genes are required for patterning of the femur (stylopod)
during embryonic development(10,15) and, given our work on
Hox11 genes, would likely be required for repair of these
structures, but this has yet to be tested. Perhaps the most
interesting question is whether different paralogs contribute in
unique ways to the bone healing and remodeling process.
Certainly, different Hox paralogs contribute to differential
patterning information during embryonic development. This
will be an important area for future study. Overall, our results
suggest that regionally specific Hox function is an important and
previously unappreciated mechanism required for successful
fracture healing.
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